HIV/AIDS vaccine survey results
Tags: AIDS vaccines; HIV-positive persons
Related Articles
- Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor. Metadilogkul, Orapun; Jirathitikal, Vichai; Bourinbaiar, Aldar S. // Journal of Biomedicine & Biotechnology;2009 Regular Issue, p1
It is extremely rare when HIV seropositive adult patients experience spontaneous loss of antibodies, that is, seroreversion. The disappearance of HIV antibodies was occasionally attributed to iatrogenic intervention-serodeconversion. Such interventions include: HAART; oral interferon; Chinese...
- Preventing Sexual Transmission of HIV. Cohen, Myron S. // Clinical Infectious Diseases;12/15/2007 Supplement 4, Vol. 45, pS287
The risk of human immunodeficiency virus (HIV) transmission during sexual activity is dependent on the infectivity of the HIV-positive individual and the susceptibility of the uninfected partner. HIV is most often transmitted during periods of high HIV load, but factors such as the type of...
- Strategies for Primary HIV Prevention That Target Behavioral Change. Safren, Steven A.; Wingood, Gina; Altice, Frederick l. // Clinical Infectious Diseases;12/15/2007 Supplement 4, Vol. 45, pS300
In the absence of a vaccine or cure, behavioral change remains the major method to prevent transmission of the human immunodeficiency virus (HIV). Public awareness campaigns that disseminate information about the risks and routes of transmission, although important, have an insufficient...
- HHS Directs $1.79B in Ryan White Funds to States. // Children & Youth Funding Report;5/22/2009, p21
The article reports that the U.S. Department of Health & Human Services (HHS) will release $1.79 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications. The grant will be funded through the Ryan White HIV/AIDS Program, which is...
- NEWS IN BRIEF: The South. // Advocate;8/13/92, Issue 609, p24
Reports on developments of interest to gays and lesbians in the Southern States, as of August 8, 1992. Ruling by a Washington, D.C., federal district judge that fire department officials acted illegally when they barred a fire-fighter from beginning work because he is HIV-positive; Testing of...
- A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals. // PLoS Pathogens;Aug2010, Vol. 6 Issue 8, p1
No abstract available.
- Viral Inhibition Assay: A CD8 T Cell Neutralization Assay for Use in Clinical Trials of HIV-1 Vaccine Candidates. Spentzou, Aggeliki; Bergin, Philip; Gill, Dilbinder; Cheeseman, Hannah; Ashraf, Ambreen; Kaltsidis, Harry; Cashin-Cox, Michelle; Anjarwalla, Insiyah; Steel, Alan; Higgs, Christopher; Pozniak, Anton; Piechocka-Trocha, Alicja; Wong, Johnson; Anzala, Omu; Karita, Etienne; Dally, Len; Gotch, Frances; Walker, Bruce; Gilmour, Jill; Hayes, Peter // Journal of Infectious Diseases;3/1/2010, Vol. 201 Issue 5, p720
We have characterized an assay measuring CD8 T cell-mediated inhibition of human immunodeficiency virus (HIV) type 1 replication, demonstrating specificity and reproducibility and employing a panel of primary HIV- 1 isolates. The assay uses relatively simple autologous cell culture and...
- S. Africa Forgets Children in AIDS Fight�U.N. // Clinical Infectious Diseases;12/1/2007, Vol. 45 Issue 11, piii
The article reports on the failure of the government to address the growth of AIDS and HIV cases in South Africa. The United Nations (UN) stresses that the epidemics have resulted towards the death of children before reaching two years of age as well as infected over 100, 000 children each year....
- HIV vaccine failure prompts Merck to halt trial. // Nature;9/27/2007, Vol. 449 Issue 7161, p390
The article reports on the failure of the human immunodeficiency virus (HIV) vaccine developed by Merck in the U.S. It is stated that the failure has caused Merck to halt its clinical trials. It reveals that the latest trial had begun in 2004 which enrolled 3,000 people considered to be at high...
